Portal vein embolization

PROCEDURE6 trials

Sponsors

Washington University School of Medicine, Hospital San Carlos, Madrid, Karolinska University Hospital, Assistance Publique - Hôpitaux de Paris, Linkoeping University

Conditions

Cancer of the LiverCholangiocarcinomaColorectal CancerHepatic NeoplasmHepatocellular Carcinoma (HCC)Liver CancerLiver DiseasesLiver Transplantation

Phase 2

Cd133+ Cell Infusion in Patients With Colorectal Liver Metastases.

CompletedNCT03803241

Hospital San Carlos, MadridColorectal Cancer

Start: 2019-05-31End: 2021-06-30Updated: 2021-09-27

Unknown Phase

4D Phase Contrast MR: Hypertrophy in Liver Cancer

TerminatedNCT02618447

Washington University School of MedicineCancer of the Liver, Liver Cancer

Start: 2014-08-05End: 2016-02-04Updated: 2017-04-07

Scandinavian Cohort Study for Optimal Use of Portal Vein Embolization

Karolinska University HospitalHepatic Neoplasm

Start: 2012-08-01End: 2022-12-31Target: 300Updated: 2022-03-31

Hepatic and Systemic Hemodynamic Modeling During Liver Surgery

RecruitingNCT05339984

Assistance Publique - Hôpitaux de ParisLiver Diseases, Liver Transplantation

Start: 2023-01-03End: 2026-06-01Target: 150Updated: 2025-06-27

Comparison of N-butyl-cyanoacrylate and Micro Parti-cles Effect in Inducing Liver Hypertrophy After PVE

CompletedNCT05660759

Linkoeping UniversityPortal Vein Embolization, Liver, Hypertrophy

Start: 2022-12-13End: 2022-12-13Updated: 2022-12-21

The Dragon PLC Trial (DRAGON-PLC)

RecruitingNCT06914648

Maastricht UniversityCholangiocarcinoma, Hepatocellular Carcinoma (HCC), Primary Liver Cancer

Start: 2025-04-01End: 2032-11-15Target: 358Updated: 2025-05-15

Related Papers

CD133 + cell infusion in patients with colorectal liver metastases going to be submitted to a major liver resection (CELLCOL): A randomized open label clinical trial.

2019-10-072 citations